Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

NorthWest Healthcare Properties Real Estate Invest 10 Convert Sub Debentures 31 March 2025 T.NWH.DB.G

Alternate Symbol(s):  NWHUF | T.NWH.UN | T.NWH.DB.H | T.NWH.DB.I

Northwest Healthcare Properties Real Estate Investment Trust is an open-ended real estate investment trust. The Company is the owner and operator of healthcare real estate infrastructure in North America, Brazil, Europe and Australasia. The principal business of the Company is to invest in healthcare real estate globally. It focuses on the cure segment of healthcare real estate, such as hospitals, medical office buildings, and clinics. Its asset class segmentation includes hospitals and healthcare facilities; medical office buildings; and life sciences, research, and education. It provides investors with access to a portfolio of international healthcare real estate infrastructure of interests in a diversified portfolio of about 196 income-producing properties located throughout major markets in North America, Brazil, Europe and Australasia. Its portfolio of medical office buildings, clinics, and hospitals is characterized by long-term indexed leases and stable occupancies.


TSX:NWH.DB.G - Post by User

Post by incomedreamer11on May 17, 2022 9:22am
379 Views
Post# 34688751

Scotia comments

Scotia comments

Emergence of AFFOPU Growth = Next Leg Up

OUR TAKE: Neutral. We maintain our SO rating with intact key estimates (Exhibit 1). By NWH standards, Q1 was fairly quiet. We think we’re 1-2 quarters from a material step-change in the business, including completion of a ~2-year deleveraging process via launching the U.K. Healthcare and U.S. JVs (Q2/22 and Q3/22, respectively; Exhibit 7), which combined with deploying excess capacity in European/Australian JVs, should double annualized fee revenues to $120M. That, in-and-of-itself, is not the important thing for us. The important thing, when combined with portfolio 2022E SSREV of ~4%, is the expected impact on AFFOPU and NAVPU growth, with our emphasis on the former. To be clear, we think unit price appreciation requires better AFFOPU growth (Exhibit 2). Successful fundraising and efficient capital allocation should get NWH there starting in 2H/22, in our view. The “defensive” portfolio has out-performed during COVID (Exhibit 3), but superior AFFOPU/NAVPU growth is the next leg up (Exhibits 4-6).

KEY POINTS

What has changed since we last wrote? We modified our model a bit as it pertains to the asset manager, lowering our multiple by ~4x to ~15.0x-15.5x (base fees = 18x; other fees = 9x) on broader recent industry compression. That said we increased our NTM and 2023E FRE (fee-related-earnings) to $55M and $64M. We also increased our development yield spread to ~160bp (from ~100bp) given NWH target 5.5%-6% yields (delivered $103M at 6% in Q1; at 100% share). We increased our 2022E/2023E debt refi costs by 110bp/100bp.

Approaching material step-change in asset management franchise that should improve investor sentiment. A key point made by NWH on its c/c was the significant acceleration of asset management fees from the Q1/22A $15M (annualized = $60M) to $120M. The key catalysts = the long-awaited UK Healthcare Fund ($1B would be deployed via seed portfolio; $2.5B of AUM targeted in total), planned U.S. co-investment into the recent $765M acquisition (say ~$200M of equity at 50% LTV and 50% co-investment) and capital deployment in its Australian and European JVs with ~$5B of capacity (i.e., say $1.6B-$1.7B of LP equity over 2-4 years), which = NWH target of ~$20B vs. the $11B today (Exhibit 7). This excludes potential JV formations in Brazil and Canada (where NWH owns 100%) Simply applying a market-standard 50%-60% GP margin to the $120M aligns with our forecast $64M of FRE in our Forward NAVPU (Exhibit 8).

Long-term potential paths taken. Over time, we would like to see LP diversification (new relationships outside of GIC) to really cement the Global franchise. As noted, the $20B AUM target excludes Brazil and Canada, where we suspect NWH will reduce its asset-heavy approach consistent with Europe and Australia today (20%-30%). In addition to bringing in co-investment capital, we think NWH could look to create geographic stand-alone REITs, transforming NWH into a completely capital-light, low-leverage asset manager (requiring conversion to a C-Corp). Lots of interesting possibilities over time to be sure.


<< Previous
Bullboard Posts
Next >>